Who makes Others except finerenone?

Others except finerenone is developed by Bayer.

What development phase is Others except finerenone in?

Others except finerenone is in Phase 2.

Last reviewed 2026-04-19 · How we verify

Others except finerenone

Bayer · Phase 2 active Small molecule

At a glance

Generic name	Others except finerenone
Sponsor	Bayer
Modality	Small molecule
Phase	Phase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

An Observational Study to Learn More About How Safe Finerenone is and How Well it Works in People With Chronic Kidney Disease and Type 2 Diabetes in Routine Medical Care in the United States

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Others except finerenone CI brief — competitive landscape report
Others except finerenone updates RSS · CI watch RSS
Bayer portfolio CI